Georgia's Online Cancer Information Center


back

Solid Tumor Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = Solid Tumor
Cancer Type = Solid Tumor
NCI ID Cancer Type Trial Name
There are currently 82 active Solid Tumor clinical trials in Georgia.
NCI ID Cancer Type Trial Name
1.
A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies
Cancer Type
Solid Tumor
NCT ID
NCT06208878
Protocol IDs
CRSP-ONC-LTF
NCI-2024-01163
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
2.
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT06270706
Protocol IDs
PLN-101095-ONC-101
NCI-2024-01965
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
3.
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT05150691
Protocol IDs
DB-1303-O-1001
NCI-2022-04237
Treatment Sites (1)
City of Hope Atlanta
Newnan
Brian Wortz, PharmD, ACRP-CP
770-400-6169
4.
A Robot (My Special Aflac Duck) for the Reduction of Medical Setting Distress in Pediatric Cancer Patients
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT04409301
Protocol IDs
AFLAC4875-19
NCI-2019-08591
Treatment Sites (2)
Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta
Atlanta
Howard M. Katzenstein, MD
404-785-0853
Winship Cancer Institute of Emory University
Atlanta
5.
NCORP Trial
A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma
Cancer Type
Ovarian Cancer, Solid Tumor, Unknown Primary, Uterine Cancer
NCT ID
NCT05548296
Protocol IDs
ACR-368-201 (GOG 3082)
NCI-2022-10629
Treatment Sites (2)
Northeast Georgia Medical Center - Gainesville
Gainesville
Trena Davis
770-219-8822
Winship Cancer Institute of Emory University
Atlanta
6.
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
Cancer Type
Hematopoietic Malignancies, Lymphoma, Non-Hodgkin Lymphoma, Solid Tumor, Unknown Primary
NCT ID
NCT04104776
Protocol IDs
0209-01
NCI-2020-01007
7.
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Cancer Type
Breast Cancer, Head and Neck Cancer, Lung Cancer, Solid Tumor, Unknown Primary
NCT ID
NCT05785741
Protocol IDs
DB-1310-O-1001
NCI-2023-06649
CTR20231736
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
8.
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors
Cancer Type
Colon/Rectal Cancer, Lung Cancer, Solid Tumor
NCT ID
NCT05726864
Protocol IDs
ELI-002-201
NCI-2023-01631
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
9.
A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT05614739
Protocol IDs
LOXO-FG3-22001
NCI-2023-00367
022-502755-59-00
2022-502755-59-00
J4G-OX-JZVA
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
10.
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT05293496
Protocol IDs
CP-MGC018-02
NCI-2022-04067
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
11.
A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS)
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT06063317
Protocol IDs
CF33-CD19-101
NCI-2023-08528
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
12.
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Cancer Type
Solid Tumor, Unknown Primary, Uterine Cancer
NCT ID
NCT05787587
Protocol IDs
IDE161-001
NCI-2023-03139
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
13.
A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)
Cancer Type
Hematopoietic Malignancies, Lymphoma, Non-Hodgkin Lymphoma, Solid Tumor, Unknown Primary
NCT ID
NCT05487170
Protocol IDs
RNK05047-01
NCI-2022-09252
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
14.
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)
Cancer Type
Brain & Spinal Cord Tumor, Colon/Rectal Cancer, Head and Neck Cancer, Lung Cancer, Neuroendocrine Tumor, Solid Tumor, Thyroid Cancer, Unknown Primary
NCT ID
NCT03157128
Protocol IDs
LOXO-RET-17001
NCI-2017-00976
2017-000800-59
Treatment Sites (1)
Emory University School of Medicine
Atlanta
15.
A Study of XMT-1660 in Participants With Solid Tumors
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT05377996
Protocol IDs
MER-XMT-1660-1
NCI-2022-04696
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
16.
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT05907304
Protocol IDs
ERAS-254-01
NCI-2024-00013
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
17.
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT05581004
Protocol IDs
GO43860
NCI-2022-08852
2021-006708-34
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
18.
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of RO7589831 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Cancer Type
Solid Tumor
NCT ID
NCT06004245
Protocol IDs
BP44474
NCI-2023-06836
2023-503170-20-00
2023-503170-20-01
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
19.
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRa)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Cancer Type
Gynecologic Cancers, Lung Cancer, Ovarian Cancer, Primary Peritoneal Cancer, Solid Tumor
NCT ID
NCT04300556
Protocol IDs
MORAb-202-G000-201
NCI-2020-06147
2019-003600-12
20.
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Cancer Type
Solid Tumor
NCT ID
NCT03391778
Protocol IDs
208750
NCI-2018-01288
ADP-0000-002
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
21.
An Internet-Based Program to Help Cancer Survivors Manage Pain, IMPACTS Study
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT04462302
Protocol IDs
WF-1901
WF-1901
WF-1901
NCI-2020-02315
22.
NCORP Trial
An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT05364086
Protocol IDs
URCC21038
URCC-21038
URCC-21038
NCI-2022-01426
Treatment Sites (21)
Atlanta Cancer Care - Alpharetta
Alpharetta
Kristin Sieverding
770-777-1315
Atlanta Cancer Care - Conyers
Conyers
404-303-3355
Atlanta Cancer Care - Cumming
Cumming
404-303-3355
Atlanta Cancer Care - Decatur
Decatur
404-303-3355
Atlanta Cancer Care - Stockbridge
Jonesboro
Andrena Jefferson
678 466-2069
Atlanta Cancer Care - Tower
Atlanta
404-303-3355
Atlanta Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
Atlanta Head and Neck Associates
Atlanta
Georgia Cancer Specialists - Athens
Athens
Cynthia Pirkle
Georgia Cancer Specialists - Canton
Canton
Georgia Cancer Specialists - CenterPointe
Sandy Springs
Anila Lokhandwala
404-256-4777 ext 9242
Georgia Cancer Specialists - Decatur
Decatur
404-303-3355
Georgia Cancer Specialists - Kennestone
Marietta
Greta Dudley
Georgia Cancer Specialists - Macon-Coliseum
Macon
Sonia Hernandez
478-745-6130 x8152
Georgia Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
John B Amos Cancer Center
Columbus
Courtney Dean Alexander
706-780-6201
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
Pearlman Cancer Center at South Georgia Medical Center
Valdosta
Jeffrey Hoy
229-259-4628
University Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
23.
Arginine and Whole Brain Radiation Therapy for the Treatment of Patients with Brain Metastases
Cancer Type
Brain & Spinal Cord Tumor, Solid Tumor, Unknown Primary
NCT ID
NCT06328686
Protocol IDs
WINSHIP5883-23
NCI-2023-10895
STUDY00005787
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
24.
AWAKE Mobile Application and Coaching Phone Calls in Improving Health-Promoting Behaviors in Adolescent Cancer Survivors and Their Guardians
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT03564587
Protocol IDs
CHOA4223-17
NCI-2018-00736
IRB00099050
Treatment Sites (1)
Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta
Atlanta
Howard M. Katzenstein, MD
404-785-0853
25.
NCORP Trial
Biospecimen Collection in Identifying Genetic Changes in Patients with Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
Cancer Type
Breast Cancer, Colon/Rectal Cancer, Kidney Cancer, Liver Cancer / Hepatoblastoma, Multiple Myeloma, Plasma cell neoplasm, Prostate Cancer , Solid Tumor, Unknown Primary
NCT ID
NCT04955808
Protocol IDs
DCP-002
DCP-002
DCP-002
NCI-2017-01572
26.
NCORP Trial
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
Cancer Type
Solid Tumor
NCT ID
NCT03996265
Protocol IDs
URCC-18007
URCC-18007
URCC-18007
NCI-2019-01528
Treatment Sites (3)
Atlanta Cancer Care - Alpharetta
Alpharetta
Kristin Sieverding
770-777-1315
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
27.
Cabozantinib and Isotretinoin in Treating Children with Relapsed or Refractory Solid Tumors
Cancer Type
Brain & Spinal Cord Tumor, Solid Tumor, Unknown Primary
NCT ID
NCT03611595
Protocol IDs
171971
NCI-2018-02497
28.
Caris Biorepository Research Protocol
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT01499394
Protocol IDs
TCBIO-001-0710
Treatment Sites (1)
Southeastern Urology Associates - Macon
Macon
Ginger Safford, RN
478-742-0932
29.
NCORP Trial
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Cancer Type
Bladder Cancer, Breast Cancer, Cervical Cancer, Colon/Rectal Cancer, Esophogeal Cancer, Head and Neck Cancer, Leukemia, Lung Cancer, Lymphoma, Multiple Myeloma, Ovarian Cancer, Prostate Cancer , Sarcoma, Solid Tumor, Stomach/ Gastric Cancer, Thyroid Cancer
NCT ID
NCT05366881
Protocol IDs
Adela-EDMRD-001
NCI-2022-04272
Treatment Sites (1)
Northeast Georgia Medical Center - Gainesville
Gainesville
Trena Davis
770-219-8822
30.
Childhood Cancer Survivor Study
Cancer Type
Brain & Spinal Cord Tumor, Hodgkin Lymphoma, Leukemia, Lymphoma, Neuroblastoma, Non-Hodgkin Lymphoma, Sarcoma, Solid Tumor
NCT ID
NCT01120353
Protocol IDs
CCSS
U24CA055727
Treatment Sites (2)
Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta
Atlanta
Howard M. Katzenstein, MD
404-785-0853
31.
NCORP Trial
CIBMTR Research Database
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT01166009
Protocol IDs
NMDP IRB-1999-0021
Treatment Sites (1)
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
32.
Collecting Blood Samples from Patients with and without Cancer to Evaluate Tests for Early Cancer Detection
Cancer Type
Breast Cancer, Head and Neck Cancer, Hematopoietic Malignancies, Kidney Cancer, Leukemia, Melanoma, Sarcoma, Solid Tumor, Thyroid Cancer, Unknown Primary
NCT ID
NCT05334069
Protocol IDs
A212102
A212102
A212102
NCI-2022-02477
Treatment Sites (1)
Low Country Cancer Care Associates, PC
Savannah
33.
Collection and Storage of Tissue and Blood Samples from Patients with Cancer
Cancer Type
Solid Tumor
NCT ID
NCT02474160
Protocol IDs
9846
9846
NCI-2015-00863
P9846
P9846_R02PAPPHOLD01
Treatment Sites (1)
Augusta University Medical Center
Augusta
Carol Terry
706-721-4430
34.
NCORP Trial
Collection of Research Data and Samples from Patients Treated with Immunotherapy to Study Its Side Effects
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT04242095
Protocol IDs
A151804
A151804
NCI-2019-07113
35.
Communication Issues in Patient and Provider Discussions of Immunotherapy
Cancer Type
Solid Tumor
NCT ID
NCT05873608
Protocol IDs
WINSHIP3293-16
NCI-2020-00828
IRB00091198
Treatment Sites (2)
Atlanta VA Medical Center
Decatur
Scott Edelman
404-728-7680
Winship Cancer Institute of Emory University
Atlanta
36.
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy, The Ice Compress Trial
Cancer Type
Solid Tumor
NCT ID
NCT05642611
Protocol IDs
SWOG-S2205
S2205
SWOG-S2205
NCI-2022-09251
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
37.
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
Cancer Type
Solid Tumor
NCT ID
NCT06279013
Protocol IDs
NRG-CC012CD
NRG-CC012CD
NRG-CC012CD
NCI-2023-10831
Treatment Sites (1)
Augusta University Medical Center
Augusta
Carol Terry
706-721-4430
38.
Digital Meditation for Postoperative Pain Control after Abdominal Surgery for Cancer
Cancer Type
Solid Tumor
NCT ID
NCT05346692
Protocol IDs
EU5450-21
NCI-2022-01830
STUDY00003299
39.
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
Cancer Type
Solid Tumor
NCT ID
NCT03742895
Protocol IDs
7339-002
NCI-2018-03519
2018-003007-19
MK-7339-002
Treatment Sites (2)
Augusta University Medical Center
Augusta
Carol Terry
706-721-4430
Winship Cancer Institute of Emory University
Atlanta
40.
NCORP Trial
EHR Tool in Assessing Heart Health among Cancer Survivors
Cancer Type
Breast Cancer, Colon/Rectal Cancer, Hematopoietic Malignancies, Hodgkin Lymphoma, Lymphoma, Non-Hodgkin Lymphoma, Prostate Cancer , Solid Tumor, Unknown Primary, Uterine Cancer
NCT ID
NCT03935282
Protocol IDs
WF-1804CD
WF-1804CD
WF-1804CD
NCI-2019-01362
Treatment Sites (1)
Northeast Georgia Medical Center - Gainesville
Gainesville
Trena Davis
770-219-8822
41.
Ensartinib in Treating Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders with ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Cancer Type
Brain & Spinal Cord Tumor, Brain Tumor, Liver Cancer / Hepatoblastoma, Neuroblastoma, Non-Hodgkin Lymphoma, Sarcoma, Solid Tumor, Wilms Tumor
NCT ID
NCT03213652
Protocol IDs
APEC1621F
APEC1621F
APEC1621F
NCI-2017-01243
Treatment Sites (1)
Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta
Atlanta
Howard M. Katzenstein, MD
404-785-0853
42.
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) with the Contrast Agent Iohexol
Cancer Type
Solid Tumor
NCT ID
NCT03997370
Protocol IDs
NRG-GY022
NRG-GY022
NCI-2019-04008
Treatment Sites (1)
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
43.
Evaluation of Sexual Toxicities in Women After Pelvic Radiotherapy
Cancer Type
Anal Cancer, Cervical Cancer, Colon/Rectal Cancer, Gynecologic Cancers, Solid Tumor, Uterine Cancer
NCT ID
NCT05394428
Protocol IDs
20-2369
NCI-2022-05850
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
44.
Faith-Based African American Cancer Survivorship Storytelling
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT03082612
Protocol IDs
EU3999-17
NCI-2017-00980
IRB00093110
Treatment Sites (1)
Grady Memorial Hospital
Atlanta
45.
NCORP Trial
Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT04960787
Protocol IDs
S1912CD
S1912CD
SWOG-S1912CD
NCI-2021-00579
Treatment Sites (1)
Northeast Georgia Medical Center - Gainesville
Gainesville
Trena Davis
770-219-8822
46.
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT05103046
Protocol IDs
UCT03008-001
NCI-2021-14000
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
47.
Genetic Information and Family Testing Platform to Facilitate Genetic Testing for Cancer Patients' Families, GIFT Study
Cancer Type
Solid Tumor
NCT ID
NCT05552664
Protocol IDs
UMCC 2022.066
NCI-2023-00010
HUM00224851
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
48.
Genetic Testing in Guiding Treatment for Patients with Brain Metastases
Cancer Type
Brain & Spinal Cord Tumor, Solid Tumor, Unknown Primary
NCT ID
NCT03994796
Protocol IDs
A071701
A071701
NCI-2019-00744
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
49.
HPVIQ-PedOnc Intervention in Maximizing HPV Vaccine Uptake in Young Cancer Survivors
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT04469569
Protocol IDs
XUAB2035
NCI-2021-00009
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
50.
NCORP Trial
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Cancer Type
Solid Tumor
NCT ID
NCT04871542
Protocol IDs
S2013
S2013
S2013
NCI-2021-01262
Treatment Sites (4)
John B Amos Cancer Center
Columbus
Courtney Dean Alexander
706-780-6201
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
Northeast Georgia Medical Center - Gainesville
Gainesville
Trena Davis
770-219-8822
Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
Dept of Clinical Research
229-312-5091
51.
NCORP Trial
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Cancer Type
Solid Tumor
NCT ID
NCT05108298
Protocol IDs
EAQ202
EAQ202
ECOG-ACRIN-EAQ202
NCI-2021-07529
Treatment Sites (1)
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
52.
Informational Meetings for Planning and Coordinating Treatment, The IMPACT Trial
Cancer Type
Brain & Spinal Cord Tumor, Brain Tumor, Liver Cancer / Hepatoblastoma, Sarcoma, Solid Tumor
NCT ID
NCT04330833
Protocol IDs
IUSCC-0705
NCI-2021-01462
53.
KZR-261 in Subjects With Advanced Solid Malignancies
Cancer Type
Colon/Rectal Cancer, Eye Cancer, Melanoma, Prostate Cancer , Solid Tumor, Unknown Primary
NCT ID
NCT05047536
Protocol IDs
KZR-261-101
NCI-2022-01096
Treatment Sites (2)
Emory University Hospital - Midtown
Atlanta
Scott Edelman
404-686-4411
Winship Cancer Institute of Emory University
Atlanta
54.
Nab-paclitaxel followed by Gemcitabine Hydrochloride in Treating Pediatric Participants with Newly-Diagnostic, Relapsed or Refractory Solid Tumors
Cancer Type
Solid Tumor
NCT ID
NCT03507491
Protocol IDs
AFLACST1603
NCI-2018-00465
IRB00098777
Treatment Sites (1)
Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta
Atlanta
Howard M. Katzenstein, MD
404-785-0853
55.
NCORP Trial
National Cancer Institute “Cancer Moonshot Biobank”
Cancer Type
Leukemia, Lung Cancer, Multiple Myeloma, Plasma cell neoplasm, Prostate Cancer , Solid Tumor
NCT ID
NCT04314401
Protocol IDs
10323
10323
NCI-2020-00750
Treatment Sites (18)
Atlanta Cancer Care - Alpharetta
Alpharetta
Kristin Sieverding
770-777-1315
Atlanta Cancer Care - Conyers
Conyers
404-303-3355
Atlanta Cancer Care - Cumming
Cumming
404-303-3355
Atlanta Cancer Care - Decatur
Decatur
404-303-3355
Atlanta Cancer Care - Stockbridge
Jonesboro
Andrena Jefferson
678 466-2069
Atlanta Cancer Care - Tower
Atlanta
404-303-3355
Atlanta Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
Georgia Cancer Specialists - Athens
Athens
Cynthia Pirkle
Georgia Cancer Specialists - Canton
Canton
Georgia Cancer Specialists - CenterPointe
Sandy Springs
Anila Lokhandwala
404-256-4777 ext 9242
Georgia Cancer Specialists - Decatur
Decatur
404-303-3355
Georgia Cancer Specialists - Kennestone
Marietta
Greta Dudley
Georgia Cancer Specialists - Macon-Coliseum
Macon
Sonia Hernandez
478-745-6130 x8152
Georgia Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
University Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
56.
Nivolumab in Treating Patients with Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT03816345
Protocol IDs
10204
10204
NCI-2019-00241
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
57.
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT04656496
Protocol IDs
STUDY000244
NCI-2021-01661
R01CA240319
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
58.
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Cancer Type
Head and Neck Cancer, Sarcoma, Solid Tumor
NCT ID
NCT04541108
Protocol IDs
PBI-MST-01
NCI-2021-10892
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
59.
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Cancer Type
Colon/Rectal Cancer, Sarcoma, Solid Tumor
NCT ID
NCT03715933
Protocol IDs
Ph1 INBRX-109
NCI-2018-03556
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
60.
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT03785249
Protocol IDs
849-001
NCI-2019-01032
Treatment Sites (10)
Northwest Georgia Oncology Centers - Austell
Austell
Mary Gilley
770-281-5131
Northwest Georgia Oncology Centers - Bremen
Bremen
Mary Gilley
770-281-5131
Northwest Georgia Oncology Centers - Carrollton
Carrollton
Mary Gilley
770-281-5131
Northwest Georgia Oncology Centers - Cartersville
Cartersville
Mary Gilley
770-281-5131
Northwest Georgia Oncology Centers - Douglasville
Douglasville
Mary Gilley
770-281-5131
Northwest Georgia Oncology Centers - Jasper
Jasper
Mary Gilley
770-281-5131
Northwest Georgia Oncology Centers - Marietta
Marietta
Mary Gilley
770-281-5131
Northwest Georgia Oncology Centers - Paulding
Hiram
Mary Gilley
770-281-5131
Northwest Georgia Oncology Centers - Villa Rica
Villa Rica
Mary Gilley
770-281-5131
University Cancer and Blood Center, LLC - Athens Medical Oncology
Athens
61.
Predicting Childhood Cancer Survivors' Transition Readiness and Transfer Outcomes, SURV Transfer Outcomes Study
Cancer Type
Solid Tumor
NCT ID
NCT04257058
Protocol IDs
CHOA4312-18
NCI-2020-07495
62.
NCORP Trial
Project: Every Child for Younger Patients with Cancer
Cancer Type
Brain & Spinal Cord Tumor, Brain Tumor, Leukemia, Neuroendocrine Tumor, Solid Tumor, Unknown Primary
NCT ID
NCT02402244
Protocol IDs
APEC14B1
NCI-2014-02057
Treatment Sites (2)
Atrium Health Navicent
Macon
Augusta University Medical Center
Augusta
Carol Terry
706-721-4430
63.
PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT05639751
Protocol IDs
PRT3789-01
NCI-2023-01949
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
64.
Registry Study for Radiation Therapy Outcomes
Cancer Type
Solid Tumor
NCT ID
NCT01255748
Protocol IDs
REG001-09
NCI-2022-04179
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
65.
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Cancer Type
Lung Cancer, Solid Tumor
NCT ID
NCT06014658
Protocol IDs
MBRC-101-001
NCI-2024-00437
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
66.
Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease
Cancer Type
Solid Tumor
NCT ID
NCT06343792
Protocol IDs
RLS-0071-203
NCI-2024-05325
Treatment Sites (1)
Northside Hospital Cancer Institute - Bone Marrow Transplant (BMT)
Atlanta
Caitlin Guzowski
404-851-8523
67.
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT02636855
Protocol IDs
ADP-0000-001
NCI-2016-01399
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
68.
Sirolimus and Metronomic Chemotherapy for the Treatment of High-Risk Solid Tumors in Children, AflacST1903 Study
Cancer Type
Sarcoma, Solid Tumor
NCT ID
NCT04469530
Protocol IDs
AFLACST1903
STUDY00000113
NCI-2020-01654
Treatment Sites (2)
Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta
Atlanta
Howard M. Katzenstein, MD
404-785-0853
Winship Cancer Institute of Emory University
Atlanta
69.
Sirolimus and Metronomic Chemotherapy in Treating Younger Patients with Recurrent and/or Refractory Solid or Central Nervous System Tumors
Cancer Type
Solid Tumor
NCT ID
NCT02574728
Protocol IDs
AFLACST1502
NCI-2015-01637
IRB00082488
Treatment Sites (1)
Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta
Atlanta
Howard M. Katzenstein, MD
404-785-0853
70.
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT04185883
Protocol IDs
20190135
NCI-2020-00134
2023-506794-35
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
71.
Standard Interval Dosing Compared to Extended Interval Dosing of Nivolumab or Pembrolizumab for the Treatment of Locally Advanced or Metastatic Cancer
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT04295863
Protocol IDs
IRB19-1718
NCI-2020-13885
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
72.
STK-012 Monotherapy and in Combination Therapy in Patients with Solid Tumors
Cancer Type
Head and Neck Cancer, Kidney Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Solid Tumor, Unknown Primary
NCT ID
NCT05098132
Protocol IDs
STK-012-101
NCI-2022-00633
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
73.
Study of CHS-114 in Participants With Advanced Solid Tumors
Cancer Type
Head and Neck Cancer, Skin Cancer (Non-Melanoma), Solid Tumor, Unknown Primary
NCT ID
NCT05635643
Protocol IDs
SRF114-101
NCI-2023-05019
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
74.
Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
Cancer Type
Cervical Cancer, Head and Neck Cancer, Liver Cancer / Hepatoblastoma, Melanoma, Sarcoma, Skin Cancer (Non-Melanoma), Solid Tumor, Unknown Primary
NCT ID
NCT05103345
Protocol IDs
SGN-P01-002
NCI-2023-06281
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
75.
Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT05067257
Protocol IDs
RTX-CAP-201
NCI-2022-04731
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
76.
SurvivorLink in Improving Quality of Life in Cancer Survivors and Caregivers
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT03543852
Protocol IDs
RSPH-AFLAC4297-18
NCI-2018-00396
IRB00101506
77.
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy
Cancer Type
Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT03394365
Protocol IDs
ATA129-EBV-302
NCI-2018-00043
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
78.
Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients with Advanced Solid Tumors, The ComBET Trial
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT05327010
Protocol IDs
10486
10486
NCI-2022-02915
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
79.
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT04768868
Protocol IDs
IMP7068 - 101
NCI-2021-13607
80.
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
Cancer Type
Brain & Spinal Cord Tumor, Brain Tumor, Kidney Cancer, Sarcoma, Solid Tumor
NCT ID
NCT05286801
Protocol IDs
PEPN2121
PEPN2121
NCI-2022-01992
81.
NCORP Trial
Use of a Genomic Tumor Board to Increase the Number of Patients with Recurrent, Refractory, Metastatic, or Newly Diagnosed Advanced Solid Tumors who Receive Genome-Informed Treatment
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT05455606
Protocol IDs
S2108CD
S2108CD
SWOG-S2108CD
NCI-2022-04626
Treatment Sites (1)
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
82.
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents with Cancer
Cancer Type
Solid Tumor, Unknown Primary
NCT ID
NCT03223753
Protocol IDs
ALTE1631
ALTE1631
COG-ALTE1631
NCI-2017-01219
About Us Research Resources & Education Screening & Genetics Clinical Trials & Providers Cancer Navigators Survivorship Media, News & Events Contact Us Donate Take Our Survey Link to Us

Research

Screening & Genetics

Find Cancer Care

Survivorship

About Georgia CORE

Education & Resources

Media, News & Events

Patient Navigation

Georgia CORE

 

Georgia CORE bridges the gap between groundbreaking research, educational outreach, and effective advocacy to transform the landscape of cancer care for all Georgians.